Short answer
DELCATH SYSTEMS, INC. (DCTH) filed its Q3 2025 10-Q quarterly report on Nov 4, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $21M (up 83.6% year over year) with net income of $830,000.
Q3 2025 key financials · XBRL
- Revenue
- $21M
- +83.6% YoY · −14.9% QoQ
- Net income
- $830,000
- −55.5% YoY · −69.2% QoQ
- Operating margin
- -1.9%
- Gross margin
- 87.2%
- EPS (diluted)
- $0.03
- −66.7% YoY · −50.0% QoQ
Source: XBRL data from the DELCATH SYSTEMS, INC. (DCTH) Q3 2025 10-Q on SEC EDGAR. USD.
DELCATH SYSTEMS, INC. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly added Medicaid pricing-compliance risk triggered by participation in MDRP, 340B, VA/FSS and TRICARE programs
- Most material update: OBBB signed July 4, 2025, potentially reducing Medicaid spending, enrollment and insurance coverage
- Regulatory exposure: Incorrect or late pricing submissions could cause civil penalties or MDRP termination
- Market risk: State drug-transparency laws could restrict price increases and impose penalties
- Tax risk: OBBB restored U.S. R&D expense deductions after December 31, 2024, but future guidance may affect deferred tax assets
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other DELCATH SYSTEMS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.